Skip to main content
Figure 1 | BMC Neurology

Figure 1

From: Effect of TTP488 in patients with mild to moderate Alzheimer’s disease

Figure 1

Estimated mean change from baseline over time on Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-cog 11). Increasing values represent worsening. Error bars represent one standard error. (A) ADAS-cog Observed cases all data. Treatment-placebo difference at 18 months = 3.1, p < 0.008; (B) ADAS-cog, on treatment observed cases. Treatment-placebo difference at 18 months = 2.7, p = 0.03.

Back to article page